Cargando…

Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions

Toxicity and resistance remain major challenges for advanced or recurrent cervical cancer therapies, as treatment requires high doses of chemotherapeutic agents. Restoration of TP53 and hypophosphorylated-retinoblastoma (pRB) proteins by human papillomavirus (HPV) E6/E7 siRNA sensitizes HPV-positive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajasekaran, Nirmal, Jung, Hun Soon, Bae, Soo Hyeon, Chelakkot, Chaithanya, Hong, Sungyoul, Choi, Jong-Sun, Yim, Dong-Seok, Oh, Yu-Kyoung, Choi, Yoon-La, Shin, Young Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570578/ https://www.ncbi.nlm.nih.gov/pubmed/28843398 http://dx.doi.org/10.1016/j.neo.2017.07.005

Ejemplares similares

Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo
por: Jung, Hun Soon, et al.
Publicado: (2015)

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells
por: Hong, D, et al.
Publicado: (2009)

SMAD4 Controls Cancer Cell Metabolism by Regulating Methylmalonic Aciduria Cobalamin Deficiency (cbl) B Type
por: Song, Kyoung, et al.
Publicado: (2022)

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
por: Chang, J T-C, et al.
Publicado: (2010)

Assessment of Tp–e interval, Tp–e/QT, and Tp-e/QTc ratios in patients with acromegaly
por: ÇELİK, İbrahim Etem, et al.
Publicado: (2022)

Evaluation of Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in patients with acute myocarditis
por: Ucar, Fatih Mehmet, et al.
Publicado: (2019)

Evaluation of Tp–e interval, Tp–e/QT ratio, and Tp–e/QTc ratio in patients with Behçet’s disease
por: Hidayet, Şıho, et al.
Publicado: (2019)

Selection Strategies and Practical Application of BRAF V600E-Mutated Non–Small Cell Lung Carcinoma
por: Hwang, Inwoo, et al.
Publicado: (2022)

Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer
por: Jayamohan, Sridharan, et al.
Publicado: (2019)

Expression data of HeLa cells treated with CENP-E siRNA or Eg5 siRNA in the presence of BubR1 siRNA
por: Nakayama, Yusuke, et al.
Publicado: (2015)

Corrigendum: Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer
por: Jayamohan, Sridharan, et al.
Publicado: (2021)

Evaluation of TP-E Interval and TP-E/QT Ratio in Panic Disorder
por: Afsin, Abdulmecit, et al.
Publicado: (2020)

Prolonged Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Type 2 Diabetes Mellitus
por: Tokatli, Alptug, et al.
Publicado: (2016)

Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios in patients with primary hyperparathyroidism and their relationship with cardiac arrhythmic events
por: YILMAZ, Yücel, et al.
Publicado: (2021)

Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy
por: Xu, Cong, et al.
Publicado: (2020)

Attenuated Salmonella carrying plasmid co-expressing HPV16 L1 and siRNA-E6 for cervical cancer therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Intestinal Epithelial Cell-Specific Deletion of PLD2 Alleviates DSS-Induced Colitis by Regulating Occludin
por: Chelakkot, Chaithanya, et al.
Publicado: (2017)

Evaluation of Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with mitral valve stenosis before and after balloon valvuloplasty
por: Dural, Muhammet, et al.
Publicado: (2017)

A Mexican Standoff: Mitral stenosis, mitral balloon valvuloplasty, Tp-e interval, Tp-e/QT and Tp-e/QTc ratios and sympathetic activity
por: Karakulak, Uğur Nadir
Publicado: (2017)

siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy
por: Shiri Aghbash, Parisa, et al.
Publicado: (2023)

Tetrazine-Induced Bioorthogonal Activation of Vitamin E-Modified siRNA for Gene Silencing
por: Zhang, Xueli, et al.
Publicado: (2022)

Evaluation of ventricular repolarization features with novel electrocardiographic parameters (Tp-e, Tp-e/QT) in patients with psoriasis
por: Arısoy, Arif, et al.
Publicado: (2017)

Evaluation of Tp-e interval, Tp-e/QT ratio and index of cardiac-electrophysiological balance in patients with tinnitus
por: Kaya, Hakan, et al.
Publicado: (2021)

New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy
por: Kumar, Krishan, et al.
Publicado: (2022)

HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
por: Ren, Shuling, et al.
Publicado: (2020)

Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract
por: Ball, Rebecca L., et al.
Publicado: (2018)

Fate of Tableted Freeze-Dried siRNA Lipoplexes in Gastrointestinal Environment
por: Rehman, Asad Ur, et al.
Publicado: (2021)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Identification of effective siRNA blocking the expression of SARS viral envelope E and RDRP genes
por: Meng, Bo, et al.
Publicado: (2006)

Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse
por: Chelakkot, Chaithanya, et al.
Publicado: (2022)

Left ventricular hypertrophy amplifies the QT, and Tp-e intervals and the Tp-e/ QT ratio of left chest ECG
por: Zhao, Zhao, et al.
Publicado: (2010)

Targeting HPV‐infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine
por: Levine, Rachel M., et al.
Publicado: (2016)

si-TP73-AS1 suppressed proliferation and increased the chemotherapeutic response of GC cells to cisplatin
por: Peng, Jianjun
Publicado: (2018)

Tp-e interval and Tp-e/QTc ratio: new choices for risk stratification of arrhythmic events in patients with hypertrophic cardiomyopathy
por: Castro-Torres, Yaniel
Publicado: (2017)

Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy
por: Akboğa, Mehmet Kadri, et al.
Publicado: (2017)

Effect of ranolazine on Tp‐e interval, Tp‐e/QTc, and P‐wave dispersion in patients with stable coronary artery disease
por: Akcay, Murat, et al.
Publicado: (2021)

HPV E6, E6AP and cervical cancer
por: Beaudenon, Sylvie, et al.
Publicado: (2008)

SiW ECAL for future e + e − collider
por: Balagura, V., et al.
Publicado: (2017)

SiW ECAL for future $e^+e^-$ collider
por: Balagura, V., et al.
Publicado: (2017)

Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation
por: Mwapagha, Lamech M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8mlf6isoo1en4js6fvisj0mnnh